Chad Schou , Justus Mukavi , Jandirk Sendker , Androulla Miliotou , Vasiliki Christodoulou , Yiannis Sarigiannis , Aleksandar Jovanovic , Thomas J. Schmidt , Panagiotis Karanis
{"title":"Antileishmanial activity of Ptilostemon chamaepeuce subsp. cyprius","authors":"Chad Schou , Justus Mukavi , Jandirk Sendker , Androulla Miliotou , Vasiliki Christodoulou , Yiannis Sarigiannis , Aleksandar Jovanovic , Thomas J. Schmidt , Panagiotis Karanis","doi":"10.1016/j.micpath.2025.107441","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Phytochemicals from unexplored plant species may be vital to unlocking pharmaceutical antibiotic and antiparasitic discoveries. New compounds need to be discovered to combat antimicrobial resistance. This study aimed to investigate ethanolic leaf extracts from five endemic and four indigenous plants from Cyprus for antibacterial, antileishmanial, and antioxidant activities.</div></div><div><h3>Methods</h3><div>Ethanolic leaf extracts were screened for antibacterial activity using a broth microdilution assay and iodonitrotetrazolium chloride (INT) as a colourimetric redox indicator for determining the minimum inhibitory concentration (MIC) against four Gram-positive and two Gram-negative American Type Culture Collection (ATCC) reference bacteria. Total phenolic content (TPC), total flavonoid content (TFC) and radical scavenging activity assays were performed to screen for antioxidant potential. <em>Leishmania infantum</em> clinical culture (MCAN/CY/2005/CD57) was used to screen the extracts for <em>in vitro</em> antileishmanial activity. Their cytotoxicity <em>in vitro</em> was assessed using the resazurin fluorometric assay with a HepG2 cell line. As an estimate of <em>in vitro</em> toxicity, a brine shrimp lethality assay was performed.</div></div><div><h3>Results</h3><div>The ethanol extract of <em>Ptilostemon chamaepeuce</em> subsp. <em>cyprius</em> (Greuter) Chrtek & B. Slavik demonstrated antibacterial activity against <em>Enterococcus faecalis</em> (ATCC 29212) with minimum inhibitory concentration (MIC) < 0.625 mg/mL and antileishmanial activity against a clinical isolate of <em>L</em><em>.</em> <em>infantum</em> (MCAN/CY/2005/CD57) from an infected dog (promastigote IC<sub>50</sub> of 105.7 ± 2.5 μg/mL and amastigote IC<sub>50</sub> of 118.5 ± 4.3 μg/mL) after 48 h and compared to the activity of the reference drug, miltefosine (IC<sub>50</sub> of 3.7 ± 0.1 μg/mL and 18.5 ± 2.3 μg/mL, respectively). Liquid-chromatography-mass spectrometry (LC-MS) analysis revealed the presence of at least five sesquiterpene lactones (STLs) in <em>P. cham</em>. subsp. <em>cyprius</em> ethanolic extract. The main compound, deacylcynaropicrin, based on its high-resolution mass spectrum, is believed to be primarily responsible for the antileishmanial activity observed <em>in vitro</em>.</div><div><em>Quercus alnifolia</em> Poech ethanolic extract showed antibacterial activity against four Gram-positive and one Gram-negative bacteria with MIC values of < 0.625 mg/mL, respectively, and antioxidant capacity in DPPH radical scavenging assay with IC<sub>50</sub> of 0.155 ± 0.002 mg/mL and compared to ascorbic acid (IC<sub>50</sub> of 0.036 ± 0.000 mg/mL) and Trolox (IC<sub>50</sub> of 0.047 ± 0.001 mg/mL).</div></div><div><h3>Conclusion</h3><div>The ethanolic extract of <em>Ptilostemon chamaepeuce</em> subsp. <em>cyprius</em> demonstrated dose-dependent antileishmanial activity. This is the first data report of <em>P</em><em>.</em> <em>cham</em><em>.</em> subsp. <em>cyprius</em> and <em>Q</em><em>.</em> <em>alnifolia</em> ethanolic extracts to indicate antibacterial, antileishmanial and antioxidant activities in preliminary investigations. Moreover, this is the first report on STLs in <em>P. cham</em>. subsp. <em>cyprius</em>, and future studies are needed to confirm if they are responsible for the <em>in vitro</em> antileishmanial activity. These findings highlight the potential of these endemic plants as sources for developing new drugs targeting Gram-positive bacterial infections and leishmaniasis, encouraging further pharmaceutical research.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"202 ","pages":"Article 107441"},"PeriodicalIF":3.3000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025001664","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Antileishmanial activity of Ptilostemon chamaepeuce subsp. cyprius
Background
Phytochemicals from unexplored plant species may be vital to unlocking pharmaceutical antibiotic and antiparasitic discoveries. New compounds need to be discovered to combat antimicrobial resistance. This study aimed to investigate ethanolic leaf extracts from five endemic and four indigenous plants from Cyprus for antibacterial, antileishmanial, and antioxidant activities.
Methods
Ethanolic leaf extracts were screened for antibacterial activity using a broth microdilution assay and iodonitrotetrazolium chloride (INT) as a colourimetric redox indicator for determining the minimum inhibitory concentration (MIC) against four Gram-positive and two Gram-negative American Type Culture Collection (ATCC) reference bacteria. Total phenolic content (TPC), total flavonoid content (TFC) and radical scavenging activity assays were performed to screen for antioxidant potential. Leishmania infantum clinical culture (MCAN/CY/2005/CD57) was used to screen the extracts for in vitro antileishmanial activity. Their cytotoxicity in vitro was assessed using the resazurin fluorometric assay with a HepG2 cell line. As an estimate of in vitro toxicity, a brine shrimp lethality assay was performed.
Results
The ethanol extract of Ptilostemon chamaepeuce subsp. cyprius (Greuter) Chrtek & B. Slavik demonstrated antibacterial activity against Enterococcus faecalis (ATCC 29212) with minimum inhibitory concentration (MIC) < 0.625 mg/mL and antileishmanial activity against a clinical isolate of L.infantum (MCAN/CY/2005/CD57) from an infected dog (promastigote IC50 of 105.7 ± 2.5 μg/mL and amastigote IC50 of 118.5 ± 4.3 μg/mL) after 48 h and compared to the activity of the reference drug, miltefosine (IC50 of 3.7 ± 0.1 μg/mL and 18.5 ± 2.3 μg/mL, respectively). Liquid-chromatography-mass spectrometry (LC-MS) analysis revealed the presence of at least five sesquiterpene lactones (STLs) in P. cham. subsp. cyprius ethanolic extract. The main compound, deacylcynaropicrin, based on its high-resolution mass spectrum, is believed to be primarily responsible for the antileishmanial activity observed in vitro.
Quercus alnifolia Poech ethanolic extract showed antibacterial activity against four Gram-positive and one Gram-negative bacteria with MIC values of < 0.625 mg/mL, respectively, and antioxidant capacity in DPPH radical scavenging assay with IC50 of 0.155 ± 0.002 mg/mL and compared to ascorbic acid (IC50 of 0.036 ± 0.000 mg/mL) and Trolox (IC50 of 0.047 ± 0.001 mg/mL).
Conclusion
The ethanolic extract of Ptilostemon chamaepeuce subsp. cyprius demonstrated dose-dependent antileishmanial activity. This is the first data report of P.cham. subsp. cyprius and Q.alnifolia ethanolic extracts to indicate antibacterial, antileishmanial and antioxidant activities in preliminary investigations. Moreover, this is the first report on STLs in P. cham. subsp. cyprius, and future studies are needed to confirm if they are responsible for the in vitro antileishmanial activity. These findings highlight the potential of these endemic plants as sources for developing new drugs targeting Gram-positive bacterial infections and leishmaniasis, encouraging further pharmaceutical research.
期刊介绍:
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.
Research Areas Include:
-Pathogenesis
-Virulence factors
-Host susceptibility or resistance
-Immune mechanisms
-Identification, cloning and sequencing of relevant genes
-Genetic studies
-Viruses, prokaryotic organisms and protozoa
-Microbiota
-Systems biology related to infectious diseases
-Targets for vaccine design (pre-clinical studies)